EDIRNA

Pioneering RNA-Editing technology to create breakthrough therapeutics for untreatable conditions

Founded 2022 11-50 employees Corporate Round Biotechnology

General Information

Company Name EDIRNA

Founded Year 2022

Employees 11-50

Industries Biotechnology

Funding Stage Corporate Round

Social

Get notified when EDIRNA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Track EDIRNA

Get real-time alerts for funding, hiring, news, and 40+ signal types.

See how it works

Discover More

Biotechnology

Industry Signals All Companies

All Signals Trend Reports

About EDIRNA

EDIRNA is an innovative biotech company founded in 2022 with the mission of pioneering RNA-Editing technology to create breakthrough therapeutics for untreatable conditions. With a focus on the biotechnology industry, the company is dedicated to discovering and developing edit-to-cure therapeutics for undruggable target conditions. The recent Corporate Round investment at 05 July 2023 from Sirnaomics demonstrates growing interest and confidence in EDIRNA's RNA-Editing technology and its potential to revolutionize the treatment of currently incurable diseases. Through its pioneering approach, EDIRNA is positioned to make significant strides in addressing unmet medical needs, offering hope to patients with conditions considered untreatable using traditional therapeutic approaches. The company's focus on RNA-Editing technology indicates an exciting future with the potential to transform the landscape of medical treatment.

Taxonomy: RNA-Editing, Biotech, Therapeutics, Undruggable Targets, Innovative Technology, Medical Breakthrough, Edit-to-Cure, Research and Development, Genetic Medicine, Biomedical Innovation

Funding Rounds & Investors (1)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Corporate Round	••••••	1	•••• ••••	05 Jul 2023

FAQ About EDIRNA

Pioneering RNA-Editing technology to create breakthrough therapeutics for untreatable conditions

EDIRNA was founded in 2022.

EDIRNA operates in the following industries: Biotechnology.

EDIRNA has approximately 11-50 employees.

EDIRNA has completed 1 funding round. The latest funding stage is Corporate Round.

We're actively collecting intelligence on EDIRNA.

Track EDIRNA to get notified

Don't just browse. Track.

Signal Tracker monitors EDIRNA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

🍪

One analytics cookie (Google Analytics). We use a single analytics cookie (Google Analytics) to understand how the site is used. Essential cookies are always on. You decide on analytics. Cookie Policy

Book a demo 30 minutes